Anant Labs

Trilostane

CAS 13647-35-3

Overview

Trilostane has been used in the treatment of Cushing's syndrome (hypercortisolism), Conn's syndrome (hyperaldosteronism), and postmenopausal breast cancer in humans. When used to treat breast cancer, trilostane is administered in combination with a corticosteroid to prevent glucocorticoid deficiency

Anant Labs manufacture and furnish high quality Trilostane impurities for global markets. Our Trilostane EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Trilostane
In Stock

Trilostane

Cat. No. ANTPRD6871Old No. ANT-TRL-000CAS 13647-35-3In Stock
WhatsApp
Technical Data
New Cat. No.ANTPRD6871
Old Cat. No.ANT-TRL-000
CAS13647-35-3
Mol. FormulaC20H27NO3
Mol. Weight329.43 g/mol
IUPAC(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile
SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)C
InChIInChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1
InChI KeyKVJXBPDAXMEYOA-CXANFOAXSA-N
Synonyms
(4alpha,5alpha,17beta)-4,5-Epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrileTrilostane13647-35-3ModrenalVetorylDesopanModrastaneTrilostanoWin-24540Trilostanum